Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Medicsen is a Spanish medical technology company at the forefront of developing a novel, smart patch for needle-free drug delivery. Their primary focus is on improving the lives of patients with chronic conditions, such as diabetes, by offering a painless, convenient, and more effective alternative to traditional injections for administering medications like insulin. Medicsen's technology utilizes sonophoresis (ultrasound waves) to temporarily increase skin permeability, allowing large molecule drugs to be delivered non-invasively. The system aims to enhance patient compliance, provide personalized dosing, and integrate with digital health platforms for better disease management.
The Madrid headquarters serves as the central hub for Medicsen's research and development, product engineering, clinical trial management, strategic partnerships, and corporate operations.
Likely located within the Madrid Science Park, offering access to advanced laboratory facilities, collaborative workspaces, and a network of other innovative tech companies and research institutions.
Medicsen fosters a highly innovative, mission-driven, and collaborative work environment. The culture emphasizes scientific excellence, agile development, and a strong focus on solving real-world patient needs in chronic care.
The Madrid location provides strategic access to a rich talent pool from local universities, research centers, and a supportive ecosystem for medtech startups, including funding opportunities and regulatory expertise within the EU.
While Medicsen is headquartered in Madrid, Spain, its ambition is global, targeting major pharmaceutical markets for its drug delivery technology. Their current global activities likely involve engaging in international R&D collaborations, participating in global medtech conferences, seeking regulatory approvals in key regions like Europe and the US, and establishing partnerships for clinical trials and future commercialization. They have received support from European-wide initiatives like EIT Health.
Parque Científico de Madrid, C/ Faraday, 7, Campus de Cantoblanco
Madrid
Community of Madrid
Spain
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Medicsen' leadership includes:
Medicsen has been backed by several prominent investors over the years, including:
Medicsen has maintained a stable core leadership team. Any recent changes would likely be focused on strengthening specific technical or commercial areas as they move towards product commercialization. No major high-profile executive exits have been publicly announced in the last 12 months. The addition of Dr. Adam Michalowski as CTO, though slightly outside the 12-month window (early 2023), was a significant recent strategic hire.
Discover the tools Medicsen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Medicsen likely uses a standard professional email format. Given the company size and common practices, the most probable formats are [first_name]@medicsen.com or [first_initial][last_name]@medicsen.com.
[first]@medicsen.com or [f][last]@medicsen.com
Format
example: eduardo@medicsen.com or ejorgensen@medicsen.com
Example
70%
Success rate
Ship2B Ventures • 2023-10-26
Medicsen successfully closed a €2.4 million funding round. The investment, led by Ship2B Ventures, also saw participation from new investors like CDTI Innvierte (through its Innvierte Economía Sostenible program) and existing partners. The capital is aimed at advancing their needle-free smart patch technology towards market launch....more
Medicsen Blog • 2023-05-15
Medicsen has been chosen by the European Innovation Council (EIC) Accelerator program, one of Europe's most competitive funding schemes. This selection provides Medicsen with up to €2.5 million in grant funding and a potential equity investment of up to €15 million to further develop and scale its innovative non-invasive drug delivery system....more
La Vanguardia • 2024-02-01
Medicsen received a loan from ENISA (Empresa Nacional de Innovación, S.A.) to further develop its needle-free insulin patch. This financial boost supports the company's efforts in advancing its technology for diabetes management....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Medicsen, are just a search away.